Central Theme: to understand the molecular basis of specific transcriptional factor and peptide growth factor signaling mechanisms that instruct lung morphogenesis, then to understand their role in the perturbation of lung morphogenesis by injury and repair, and then to use this information to devise and evaluate novel rational therapeutic approaches. Project 1. Positive and negative regulators of lung development: will determine the role of the Nkx 2.1 family of transcriptional factors as key temporo-spatial developmental cues for normal lung morphogenesis, and will determine how Nkx 2.1 is positively and negatively regulated by peptide growth factor signaling. Project 2. TGF-beta signaling in lung morphogenesis, injury and repair: will further determine the role of endogenous TGF-beta peptide growth factor signaling in lung morphogenesis, and of excessive TGF-beta peptide expression and signaling in lung injury and repair, including its role in regulating epithelial apoptosis. Project 3. TGF-beta signaling and apoptosis: will determine the specific molecular signal transduction mechanism by which TGF-beta mediates activation of apoptosis and will relate these findings to lung injury and repair. Project 4. TGR-beta3 in lung morphogenesis, injury and repair: will further determine the specific functional roles of TGF-beta3 peptides in lung development, injury and repair/healing using novel regulatable transgenic/null mutant strategies. Project 5. TGR-beta rational therapeutics: will devise and test novel rationally based approaches to perturbing TGF-beta ligand-receptor interactions, based on functional predictions from computer modeling of ligand-receptor interactions and establish their utility in modulating excess TGF-beta signaling in lung injury and repair.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
3P01HL060231-02S2
Application #
6139663
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
1998-04-01
Project End
2003-03-31
Budget Start
1999-05-01
Budget End
2000-03-31
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Children's Hospital of Los Angeles
Department
Type
DUNS #
094878337
City
Los Angeles
State
CA
Country
United States
Zip Code
90027
Buckley, Susan; Shi, Wei; Xu, Wei et al. (2015) Increased alveolar soluble annexin V promotes lung inflammation and fibrosis. Eur Respir J 46:1417-29
Xing, Yiming; Wang, Runming; Li, Changgong et al. (2015) PTEN regulates lung endodermal morphogenesis through MEK/ERK pathway. Dev Biol 408:56-65
Li, Changgong; Li, Aimin; Xing, Yiming et al. (2013) Apc deficiency alters pulmonary epithelial cell fate and inhibits Nkx2.1 via triggering TGF-beta signaling. Dev Biol 378:13-24
Gong, Dapeng; Fei, Fei; Lim, Min et al. (2013) Abr, a negative regulator of Rac, attenuates cockroach allergen-induced asthma in a mouse model. J Immunol 191:4514-20
Gong, Dapeng; Shi, Wei; Yi, Sun-ju et al. (2012) TGF? signaling plays a critical role in promoting alternative macrophage activation. BMC Immunol 13:31
El-Hashash, Ahmed H K; Turcatel, Gianluca; Varma, Saaket et al. (2012) Eya1 protein phosphatase regulates tight junction formation in lung distal epithelium. J Cell Sci 125:4036-48
Xu, Pinglong; Liu, Jianming; Derynck, Rik (2012) Post-translational regulation of TGF-* receptor and Smad signaling. FEBS Lett 586:1871-84
Tiozzo, Caterina; Danopoulos, Soula; Lavarreda-Pearce, Maria et al. (2012) Embryonic epithelial Pten deletion through Nkx2.1-cre leads to thyroid tumorigenesis in a strain-dependent manner. Endocr Relat Cancer 19:111-122
Lamouille, Samy; Connolly, Erin; Smyth, James W et al. (2012) TGF-?-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion. J Cell Sci 125:1259-73
Xu, Pinglong; Liu, Jianming; Sakaki-Yumoto, Masayo et al. (2012) TACE activation by MAPK-mediated regulation of cell surface dimerization and TIMP3 association. Sci Signal 5:ra34

Showing the most recent 10 out of 126 publications